What Does the Future of Travel Look Like? A Majority of Consumers Favor a Journey Straight from the Couch to the Gate
As the summer travel season kicks off, consumers are ready to take to the skies to get away to relaxing vacations. The only problem? Getting there.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005376/en/
A new consumer survey released today by iProov, the world leader in biometric face authentication technology, found that travelers do not find the airport check-in process a relaxing first step to a destination. In fact, a majority of those surveyed would prefer to streamline the process to go straight from their couch at home to the gate in as few steps as possible.
Eighty-five percent (85%) of the 16,000 respondents in eight countries would use or would consider using a ticket/ID check from home. Further, 70% of respondents said the first step of the journey–waiting in long check-in lines–is the most annoying part of traveling.
So, how can airports and airlines reduce the bottlenecks during journeys using check-from-home services to make the travel experience more convenient for consumers? Secure remote verification technology enables travelers to complete their ticket and ID checks from the comfort of their homes, so they don't need to do it at the airport. The key to this process is facial biometric verification and authentication.
“Secure verification technology enables travelers to complete their ticket and ID checks from the comfort of their homes, so they don't need to do it at the airport,” said Andrew Bud, Founder and CEO of iProov. “Facial biometric verification and authentication are key to this process. Face verification has already proved to be a secure and accessible solution for many applications and processes–for example, nearly a third of consumers are already using face verification to access their mobile banking apps. We’ve shown that online face verification can be applied to improve the consumer travel experience, making life easier for travelers and operators around the world.”
iProov’s Genuine Presence Assurance® offers a brief, passive face scan that confirms a remote traveler is the right person, matching the identity to a trusted identity document and ticket. The technology also verifies that the user is a real person and not a presentation attack using a photo or mask, and that they are authenticating in real time. At the airport, a traveler’s face is their ticket as they choose to pass through a biometric corridor and authenticate their identity.
This technology solution is not unique to the airline industry and can be applied to eliminate check-in bottlenecks for other forms of travel, including trains, cruise ships, car hires and more. In fact, earlier this year, iProov partnered with Eurostar for the successful trial of a remote fast-track service, SmartCheck, showing that the future of travel is not so distant.
To learn more about iProov and the future of travel, please visit the Biometric Travel & Check-In section of our website.
Methodology
This report is based on research carried out by an independent agency on behalf of iProov in April–May 2022. Eight countries were included in the research (the U.S., Canada, Mexico, Germany, Italy, Spain, the UK and Australia), with 2000 consumers surveyed in each country. The 16,000 respondents were not chosen for any preferences on travel–many had never flown before.
About iProov
Launched in 2013, iProov is the world leader in online facial biometric authentication, working with governments, banks and other enterprises to securely verify customer identity. Used for effortless onboarding and authentication, customers include the U.S. Department of Homeland Security, the UK Home Office, the UK National Health Service (NHS), the Australian Taxation Office, GovTech Singapore, Rabobank, ING, and others. iProov’s technologies include Liveness Assurance™ and Genuine Presence Assurance®, which ensures that an online customer is the right person, a real person, and is authenticating right now. This protects against spoof attacks from photos, videos, masks and digital injection attacks and the emerging threat of deepfakes. iProov was recognized as a Gartner Cool Vendor 2020 in Identity Access Management & Fraud Detection. For more information, please see www.iproov.com or follow us on LinkedIn or Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607005376/en/
Contact information
Rob Tacey
rob.tacey@iproov.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HP Becomes Sisvel Wi-Fi 6 Pool Licensee, Ending Disputes with Wilus, Huawei and Philips18.11.2025 11:58:00 EET | Press release
HP Inc and Sisvel have concluded an agreement for the Palo Alto-based global technology leader to become a licensee of the Sisvel Wi-Fi 6 patent pool. The deal follows a mediation process ordered by Judge Rodney Gilstrap, of the US District Court for the Eastern District of Texas, as part of patent infringement litigation brought against HP by Wilus Institute of Standards and Technology, a licensor in the pool. The agreement not only ends the Wilus suit, but also actions launched against HP by other Sisvel Wi-Fi 6 pool licensors, Huawei and Philips. HP now has one-stop access to approximately 2,000 patents (245 patent families) recognised to date, through the pool’s process of independent patent evaluations, as essential to the 802.11ax Wi-Fi 6 standard. Close to 40 entities license the patents in the Sisvel Wi-Fi 6 patent pool. In addition to HP Inc, these include other recent additions such as Cisco, Netgear and Acer. “We are grateful to HP for the constructive way in which they enga
Europe's GetVocal raises $26m to scale trustworthy conversational agents for enterprises18.11.2025 11:00:00 EET | Press release
GetVocal, Europe’s leading provider of conversational AI agents for enterprise customer support, today announced the closing of a $26 million Series A investment round led by Creandum with participation from Elaia and Speedinvest, bringing GetVocal’s total fundraising to $30 million. GetVocal will use the funding to fuel product innovation, market expansion, and hiring across Europe as the company accelerates its mission to help enterprises build hybrid human-AI workforces. Founded in 2023 by AI entrepreneurs Roy Moussa and Antonin Bertin, GetVocal is headquartered in Paris, with a 60-strong team spread across Europe. It serves 23 markets, with a stronghold in France and Portugal, and a rapidly growing presence in the UK and DACH. The company tackles one of the biggest barriers to conversational AI adoption – the lack of trust and confidence in black-box autonomous systems – by building trustworthy, transparent, and governed AI agents that accelerate the customer experience (CX) market
Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 10:05:00 EET | Press release
Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio
SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 10:00:00 EET | Press release
SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive long-term growth. “We are thrilled to welcome Oliver to SkySparc’s leadership team,” said Jo
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 09:23:00 EET | Press release
Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline infusion preparation, reduce healthcare professionals’ workload, and support hospital operational efficiency.3 The Remsima™ IV liquid formulation is approved in the EU for all indications of IV infliximab, matching the approved uses of all existing IV infliximab powder formulations, including rheumatoid arthritis (RA), adult and pediatric Crohn’s disease (CD), ulcerative colitis (UC), pediatric UC, ankylosing spondylitis (AS), psoriatic arthritis (PsA), and psoriasis (PsO).1 The comparability between lyophilized powder formulation and the liquid formulation of IV infliximab has been established through comprehensive chemistry, manufacturing, and controls data.2 The stability of the liquid formulation of I
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
